|
|
|
|
|
|
Introducing Our Distinguished Speakers for the 19th ASNO Annual Meeting!
|
|
|
|
We are thrilled to announce the lineup of distinguished speakers who will be sharing their expertise at the 19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting, taking place at the One Farrer Hotel in Singapore from 16 – 18 August 2024.
|
|
Our annual meeting serves as a pivotal platform for regional and international medical professionals to converge, exchange knowledge, and pool their collective expertise in the realms of diagnosis, treatment, pathology, and the biology of brain tumours. We are proud to present a lineup of speakers whose insights and contributions are at the forefront of shaping the future of Neuro-Oncology.
|
|
|
|
Day 1 - 16 August 2024
Plenary 1 IDH – Mutant Low Grade Glioma
|
|
Time: 0800hrs – 0820hrs
Biologic and Therapeutic Roles of IDH Mutation
|
|
|
|
|
|
Speaker: Prof. Hai Yan
Research Director
Institute of Molecular & Cell Biology (IMCB)
A*STAR
|
|
|
|
|
|
|
Time: 0820hrs – 0840hrs
Clinical Development of IDH Inhibitor
|
|
|
|
|
|
Speaker: Dr. Patrick Wen
Professor of Neurology
Harvard Medical School
|
|
|
|
|
|
|
Time: 0840hrs – 0900hrs
Awake Craniotomy for Low Grade Glioma
|
|
|
|
|
|
Speaker: Prof. Hugues Duffau MD, PhD
Professor and Chairman of the Neurosurgery Department
Montpellier University Medical Center
|
|
|
|
|
|
|
Time: 0900hrs – 0920hrs
Precision Radiotherapy Approaches for Minimizing Toxicity in Low Grade Gliomas
|
|
|
|
|
|
Speaker: Dr. Rakesh Jalali MD, FICRO, FRCP (Edin.)
Medical Director
Apollo Proton Cancer Centre (APCC), Chennai, India
|
|
|
|
|
|
|
|
|
|
| Click here |
|
for more information
about our speakers
and full programme
|
|
|
|
|
We invite you to join us at the 19th ASNO Annual Meeting to benefit from the insights of our esteemed speakers and to contribute to the vibrant exchange of ideas that defines our conference. Act swiftly to take advantage of the extended early bird registration until 17 May 2024.
|
| REGISTER NOW |
 |
|
|
Connect with us on LinkedIn for more updates:
|
|
|
| Contact us |
|
|
|
|
|
|
